Drug Database
Back to search

Belgium· BE-AMP-SAM124424-00

Persantine Retard 200 mg

A dipyridamole product containing dipyridamole, registered in Belgium by Boehringer Ingelheim. The same ATC class is registered in 11 of our 19 countries.

ATC B01AC07

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedPersantine Retard 200 mgATCB01AC07REGISTER NO.BE-AMP-SAM124424-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dipyridamoleAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dipyridamole is registered in 11 of 19 countries.

Countries holding a registration under ATC B01AC07 (dipyridamole), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose
Search dipyridamole products by name

Dipyridamole · ATC B01AC07

11 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Dipyridamole
Manufacturer
Boehringer Ingelheim
Country
Belgium (BE)
ATC code
B01AC07
ATC class
Dipyridamole
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    0829200
  • be_apb
    0714568

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

352 interactions on record for dipyridamole.

Graded by severity as the source publishes them — 47 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check dipyridamole against other medicinesHow interaction checks work

Dipyridamole · interactions on record

352 records

  • 47 severe
  • 93 moderate
  • 5 minor
  • 207 info

Most severe, free to view

  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe
  • DanaparoidB01AB09severe
  • TinzaparinB01AB10severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dipyridamole in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dipyridamole products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

  • Austria · Persantin
  • Bulgaria · Антистенокардин, Биокардин
  • Cyprus · Perazodin, Persantin
  • Denmark · Dipyridamol Alternova, Dipyridamol Strides
  • Spain · Persantin
  • Finland · Persantin
  • France · Persantine
  • United Kingdom (Northern Ireland) · Attia, Dipyridamole Dr. Reddy’s
  • Greece · Persantin
  • Croatia · Persantin
  • Ireland · Pyranistole
  • Iceland · Persantin
  • Italy · Corosan, Persantin
  • Malta · Perazodin
  • Netherlands · Dipyridamol Glenmark, Dipyridamol Sandoz
  • Norway · Aponova, Dipyridamol Glenmark
  • Portugal · Dipiridamol Labesfal, Persantin
  • Sweden · Dipyridamol Alternova, Pyranistole

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d5e39c5b-a7c2-4b78-aa87-83b07bca72af
GET /v1/drugs/d5e39c5b-a7c2-4b78-aa87-83b07bca72af?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Modified-release capsule, hard",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Persantine Retard 200 mg",
  "name_fr": "Persantine Retard 200 mg",
  "name_nl": "Persantine Retard 200 mg",
  "amp_code": "SAM124424-00",
  "strengths": [
    "200.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Dipyridamole"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Dipyridamole",
  "authorisation_numbers": [
    "BE124424"
  ]
}
API referenceMCP serverPlans

See everything about dipyridamole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console